Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 93

    1.

    The receptor RAGE: Bridging inflammation and cancer.

    Riehl A, Németh J, Angel P, Hess J.

    Cell Commun Signal. 2009 May 8;7:12.

    PMID:
    19426472
    [PubMed]
    Free PMC Article
    2.

    Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.

    Schmidt AM, Yan SD, Wautier JL, Stern D.

    Circ Res. 1999 Mar 19;84(5):489-97. Review.

    PMID:
    10082470
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    RAGE: a multi-ligand receptor unveiling novel insights in health and disease.

    Alexiou P, Chatzopoulou M, Pegklidou K, Demopoulos VJ.

    Curr Med Chem. 2010;17(21):2232-52. Review.

    PMID:
    20459381
    [PubMed - indexed for MEDLINE]
    4.

    RAGE and RAGE ligands in cancer.

    Logsdon CD, Fuentes MK, Huang EH, Arumugam T.

    Curr Mol Med. 2007 Dec;7(8):777-89. Review.

    PMID:
    18331236
    [PubMed - indexed for MEDLINE]
    5.

    The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond.

    Ramasamy R, Yan SF, Schmidt AM.

    Trends Cardiovasc Med. 2005 Oct;15(7):237-43. Review.

    PMID:
    16226677
    [PubMed - indexed for MEDLINE]
    7.

    RAGE and its ligands in bone metabolism.

    Zhou Z, Xiong WC.

    Front Biosci (Schol Ed). 2011 Jan 1;3:768-76. Review.

    PMID:
    21196410
    [PubMed - indexed for MEDLINE]
    8.

    RAGE: the beneficial and deleterious effects by diverse mechanisms of actions.

    Han SH, Kim YH, Mook-Jung I.

    Mol Cells. 2011 Feb;31(2):91-7. Epub 2011 Jan 18.

    PMID:
    21347704
    [PubMed - indexed for MEDLINE]
    9.

    [Role of the receptor for advanced glycation end products (RAGE) in inflammation].

    Mosquera JA.

    Invest Clin. 2010 Jun;51(2):257-68. Review. Spanish.

    PMID:
    20928981
    [PubMed - indexed for MEDLINE]
    10.

    Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.

    Lue LF, Yan SD, Stern DM, Walker DG.

    Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):249-66. Review.

    PMID:
    15975028
    [PubMed - indexed for MEDLINE]
    11.

    The ligand/RAGE axis: lighting the fuse and igniting vascular stress.

    Yan SF, Naka Y, Hudson BI, Herold K, Yan SD, Ramasamy R, Schmidt AM.

    Curr Atheroscler Rep. 2006 May;8(3):232-9. Review.

    PMID:
    16640960
    [PubMed - indexed for MEDLINE]
    12.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    13.

    Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products.

    Valencia JV, Mone M, Koehne C, Rediske J, Hughes TE.

    Diabetologia. 2004 May;47(5):844-52. Epub 2004 May 1.

    PMID:
    15127201
    [PubMed - indexed for MEDLINE]
    14.

    Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.

    Basta G.

    Atherosclerosis. 2008 Jan;196(1):9-21. Epub 2007 Sep 10. Review.

    PMID:
    17826783
    [PubMed - indexed for MEDLINE]
    15.

    Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.

    Stern DM, Yan SD, Yan SF, Schmidt AM.

    Ageing Res Rev. 2002 Feb;1(1):1-15. Review.

    PMID:
    12039445
    [PubMed - indexed for MEDLINE]
    16.

    Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings.

    Stern D, Yan SD, Yan SF, Schmidt AM.

    Adv Drug Deliv Rev. 2002 Dec 7;54(12):1615-25. Review.

    PMID:
    12453678
    [PubMed - indexed for MEDLINE]
    17.

    Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.

    Yan SF, Ramasamy R, Schmidt AM.

    Nat Clin Pract Endocrinol Metab. 2008 May;4(5):285-93. Epub 2008 Mar 11. Review.

    PMID:
    18332897
    [PubMed - indexed for MEDLINE]
    18.

    Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.

    Kim W, Hudson BI, Moser B, Guo J, Rong LL, Lu Y, Qu W, Lalla E, Lerner S, Chen Y, Yan SS, D'Agati V, Naka Y, Ramasamy R, Herold K, Yan SF, Schmidt AM.

    Ann N Y Acad Sci. 2005 Jun;1043:553-61. Review.

    PMID:
    16037278
    [PubMed - indexed for MEDLINE]
    19.

    RAGE signaling sustains inflammation and promotes tumor development.

    Gebhardt C, Riehl A, Durchdewald M, Németh J, Fürstenberger G, Müller-Decker K, Enk A, Arnold B, Bierhaus A, Nawroth PP, Hess J, Angel P.

    J Exp Med. 2008 Feb 18;205(2):275-85. Epub 2008 Jan 21.

    PMID:
    18208974
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    The biology of the receptor for advanced glycation end products and its ligands.

    Schmidt AM, Yan SD, Yan SF, Stern DM.

    Biochim Biophys Acta. 2000 Dec 20;1498(2-3):99-111. Review.

    PMID:
    11108954
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk